Refine by
Image Guided Surgery Articles & Analysis
23 news found
More importantly, NIR quantum dots consist of stronger penetration capability in tumor-targeted imaging, which can effectively avoid tissue absorption and autofluorescence. ...
National Institutes of Health (NIH)’s National Cancer Institute (NCI) to advance development of its proprietary device for Fluorescence-Guided Surgery (FGS). OnLume has developed novel FGS imaging technology to illuminate critical anatomy in real-time during surgery to optimize precision, which can lead to improved patient ...
OnLume Inc., a Madison, Wisconsin-based medical imaging company with unique technology for improving surgical precision in the operating room, has announced the start of participation in a clinical trial combining its fluorescence-guided surgery (FGS) imaging device with a novel nerve-targeting agent. ...
“We have been at the forefront of image-guided surgery with novel molecular markers and advanced imaging modalities for several years. ...
The development of the new software is aligned with the company’s mission to accelerate access to faster, safer, and smarter medical imaging. Subtle continues to expand product lines in an effort to build a comprehensive ecosystem of solutions that support all imaging needs. Fluoroscopy is a common tool for image-guided ...
Previously it had received NMPA approval for Navient ENT model. Navient, an image-guided surgical navigation system, is like a GPS for the surgeon to navigate inside the patient skull. ...
ByClaroNav
Avelas is developing pegloprastide (AVB-620), a novel fluorescent imaging agent used in combination with a fluorescence camera system, which has FDA Breakthrough Therapy Designation, for the intraoperative detection and visualization of positive margins during breast cancer surgery. The goal of intraoperative image-guided ...
This achievement expands the applications and functionality of the FLASH Navigation System for cranial surgery and minimally invasive spine surgery for the European market and additional global regions. ...
” The 7D FLASH Navigation System uses visible light to create a three-dimensional image for surgical navigation in just seconds, which is expected to result in shorter and more efficient spinal procedures. ...
OnLume Surgical, a Wisconsin-based medical device company developing novel imaging systems for use during surgery, announced the completion of its Series A funding to assist its plans for commercial launch. ...
Positive margins can be a sign that cancer may be left behind, requiring a second surgery. “We now have clarity on the development path to make fluorescence image-guided surgery the new standard of care for breast cancer lumpectomies,” said Jay Lichter, Ph.D., Chairman, President, and Chief Executive Officer of ...
“This pivotal clinical data is a first in the field of fluorescence image-guided surgery for breast cancer and supports the use of pegloprastide to revolutionize surgical treatment with the goal of eliminating tens of thousands of repeat surgeries undertaken to address positive ...
This novel platform is also capable of hosting other proprietary endomicroscopic architectures with imaging capabilities at other wavelengths supporting fluorescence-guided surgery and molecular imaging. ...
The Cellvizio®100 series system with all its different Confocal Miniprobes™ is now cleared for use with the fluorescein dye to image blood flow in the microvasculature and capillaries Mauna Kea Technologies today announced that it has received U.S. ...
SurgiMab is proud to be a sponsor of this internationally acknowledged conference, that gathers together the best specialists of Fluorescence Guided Surgery. Don’t miss the presentations by André Pèlegrin: Antibodies, favorite tools for fluorescence-guided surgery, 02/02 at 10:30 and by Ruben Meijer: ...
BySurgiMab
SurgiMab, a late-stage biotechnology company pioneering a new antibody-based fluorescence-guided approach with the aim to improve cancer surgery and clinical outcomes for patients, today announces that the first US patient has been recruited into its on-going pivotal Phase 3 clinical trial evaluating its investigational imaging agent SGM-101 in ...
BySurgiMab
Jan 11, 2019 –SafeHeal, an innovator in the field of digestive surgery, has concluded its first-in-human clinical study for its novel Colovac bypass sheath in patients undergoing colorectal surgery. ...
BySafeHeal
He currently serves as CEO and chairman of the board of directors of INSIGHTEC, which delivers incisionless surgery using focused ultrasound guided by MRI. A longtime innovator and entrepreneur, Dr. Ferré has founded and managed several world-leading companies in the field of precision, robotic, and image-guided ...
Jan 29, 2018 – The study will evaluate safety and efficacy of the Colovac bypass device for ostomy-free anastomosis protection following colorectal surgery SafeHeal, a leading innovator in the field of digestive surgery and developer of the Colovac device, announces today that it has enrolled the first five patients in its CE mark ...
BySafeHeal
SurgiMab and Quest Medical Imaging, a leader in the market for multispectral cameras, announced today that they have entered into a collaboration agreement for the upcoming Phase III clinical trial of Surgimab’s SGM-101 in fluorescent guided colorectal cancer surgery. ...
BySurgiMab